http://wapo.st/K7vTBPWhat’s in a name? That’s a question that experts are wrestling with as they prepare to revise the diagnostic manual that spells out the criteria for addiction and other substance-use problems.The catalyst for this discussion is a set of proposed changes to the Diagnostic and Sta

A special conference in the coming week on 13-15 May 2013 is another eye—catching event for the Health Technology Assessment (HTA) circles, especially in the Asia-Pacific region. The HTAsiaLink, a collaborative network between Asian Health Technology Assessment agencies, together with honorable gues

This virtual workshop was provided for public health professionals, researchers, and policy makers from Ghana, Malawi, and Tanzania. The course covered topics such as political economy of vaccinology, vaccine policy and distribution, and the science of vaccines, with a specific focus on the COVID-19 pandemic and COVID-19 vaccines.

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P 1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal

It was quite an experience this time for it was both hectic and enriching. Pempa and I (Deepika Adhikari) are researchers from Bhutan and we were recently in Thailand for training and simultaneously attended the Prince Mahidol Award Conference (PMAC) too. We are grateful to the Health Intervention a

Inequalities of health exist across the globe, between genders, socioeconomic groups, ethnicities, geographic regions, and many other characteristics. Health interventions rarely, if ever, have a uniform impact on all the groups that are eligible to receive them, yet most economic evaluations only q

Project ConsultantSripen TantivessPattara LeelahavarongNetnapis Suchonwanich59002017R2021L4Drug procurement,price performance,public hospital,พระราชบัญญัติการจัดซื้อจัดจ้างและการบริหารพัสดุภาครัฐ

(Reuters) – Victims of thalidomide said on Saturday an apology from the German inventor of the drug that caused birth defects in thousands of babies around the world was too little too late.Thalidomide, developed by the German firm Gruenenthal, was marketed internationally to pregnant women in the l

(Reuters) – GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech company for three months, sources familiar with the situation said on Sunday.The British pharmaceutical giant could sweeten its pr

The Indonesian government is strongly committed to Universal Health Coverage and acknowledges that health technology assessment (HTA) as an important tool for setting priorities for the health benefits package. Since the establishment of the HTA Committee, a number of Ministry of Health (MOH) and ac